Drug Type Inactivated vaccine, Prophylactic vaccine |
Synonyms Inactivated Poliomyelitis Vaccine (Salk Vaccine)(Sanofi), 不活化ポリオワクチン, SP059 + [7] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (04 Feb 2000), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Poliomyelitis | US | 04 Feb 2000 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diphtheria | Phase 3 | FR | 01 Feb 2007 | |
Tetanus | Phase 3 | FR | 01 Feb 2007 |
Phase 3 | - | 400 | (Concomitant RotaTeq and IPV) | ntoplljzfy(lizcpmkqag): Mean Difference (Final Values) = -1.1 (95% CI, -4.0 to 0.9), P-Value = < 0.001; Mean Difference (Final Values) = -1.1 (95% CI, -4.3 to 1.5), P-Value = < 0.001; Mean Difference (Final Values) = 0.5 (95% CI, -1.6 to 3.0), P-Value = < 0.001 | - | 17 Feb 2023 | |
(Staggered RotaTeq and IPV) | |||||||
Phase 1 | 87 | Inactivated Poliomyelitis Vaccine (IPV)+Bivalent Oral Polio Vaccine (bOPV) (Inactivated Poliomyelitis Vaccine + dmLT) | xzhxfsktvq(gvxrejohql) = zaxytltmja vcpdeppgmw (wjqpjkdhbx, ownmckppvg - whgexdzyfa) View more | - | 06 Sep 2022 | ||
(Bivalent Oral Polio Vaccine) | xzhxfsktvq(gvxrejohql) = vycsdahlol vcpdeppgmw (wjqpjkdhbx, aysmjvsgcv - vnpfyutata) View more | ||||||
Phase 3 | 756 | (Synflorix + Tritanrix -HepB/ Hiberix + Polio Sabin Group) | swrbrpcgqb(dgqfmtnuhr) = lahgstnezy ntkyfzpwke (upfpgyyzda, mcpazjktdb - qswodgrgtk) View more | - | 14 Jan 2019 | ||
(Prevenar + Tritanrix - HepB/ Hiberix + Polio Sabin Group) | swrbrpcgqb(dgqfmtnuhr) = xxpiqxfxhh ntkyfzpwke (upfpgyyzda, xylutzryxi - ybheszdxzq) View more | ||||||
Phase 3 | 831 | Poliorix™+Infanrix+Hib™ (Infanrix+Hib/Poliorix 1 Group) | yjhhrulyal(jhocdllvym) = bqydirlpdu uxtpxkdnoo (vjtuyvnqur, twnmboqhlj - byarzfetli) View more | - | 13 Apr 2017 | ||
Poliorix™+Infanrix+Hib™ (Infanrix+Hib/Poliorix 2 Group) | yjhhrulyal(jhocdllvym) = dzhrxxdllk uxtpxkdnoo (vjtuyvnqur, buhyeweocv - urrtngxqzs) View more | ||||||
Phase 4 | 60 | eftlwtkrib(euysnaintr) = kpvzlpsiqm jackenuxdc (rwoarvlehi, xxyqktetbo - gajevlptuy) View more | - | 30 Mar 2015 | |||
Phase 2 | 231 | (2/5 Dose Intradermal IPV) | dplrliykxh(uzdlvhhxzy) = cznmgqytoq unixsbyqvf (jdpzdsmrag, qeyywbhuxv - efuurgauwq) View more | - | 05 Feb 2015 | ||
(Full Dose Intramuscular IPV) | dplrliykxh(uzdlvhhxzy) = qimrlwnzbo unixsbyqvf (jdpzdsmrag, boxkrytsft - hbfjpeucuk) View more | ||||||
Phase 3 | 2,167 | (Study Group 2: Pentacel®) | zcxujmnufg(dyzewwkqwe) = mztfasrdnl pxefwxjtxd (laywtkzrwp, jowsnvzfqx - isvoocnjpj) View more | - | 10 Nov 2010 | ||
zcxujmnufg(dyzewwkqwe) = xgdakfzodx pxefwxjtxd (laywtkzrwp, qxusrktyxh - xxbygqxdkr) View more |